Award
NIH Reporter #5K08CA245206-05
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
Recipient
Sloan-Kettering Institute for Cancer Research
Award Amount
$260,099.00
Ceiling
$260,099.00
Awarded
June 26, 2024
Identifier
5K08CA245206-05
NIH grant awarded to study the combined effects of chemotherapy and T cell checkpoint inhibition in lung cancer, focusing on cellular senescence and immune response mechanisms.
Description
This NIH grant supports research on the mechanisms of chemotherapy and immunotherapy in lung cancer, focusing on cellular senescence and immune response. The project involves collaboration between Memorial Sloan Kettering Cancer Center and leading experts in cancer biology and immuno-oncology.